Q1 Earnings Estimate for Ayr Wellness Issued By Roth Capital

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Equities research analysts at Roth Capital decreased their Q1 2025 earnings per share estimates for Ayr Wellness in a research report issued to clients and investors on Monday, March 10th. Roth Capital analyst W. Kirk now expects that the company will post earnings of ($0.34) per share for the quarter, down from their prior estimate of ($0.32). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.31) per share. Roth Capital also issued estimates for Ayr Wellness’ Q2 2025 earnings at ($0.32) EPS, FY2025 earnings at ($1.26) EPS and FY2026 earnings at ($1.14) EPS.

Several other research firms also recently issued reports on AYRWF. Roth Mkm cut their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a research report on Thursday, November 14th. Atb Cap Markets downgraded Ayr Wellness from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 13th. Finally, Ventum Cap Mkts downgraded Ayr Wellness from a “strong-buy” rating to a “hold” rating in a research report on Friday, March 7th.

Ayr Wellness Price Performance

OTCMKTS AYRWF opened at $0.17 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.59 and a quick ratio of 0.58. The stock’s fifty day moving average price is $0.41 and its 200 day moving average price is $1.02. Ayr Wellness has a 1 year low of $0.16 and a 1 year high of $3.46. The company has a market cap of $19.75 million, a price-to-earnings ratio of -0.08 and a beta of 1.70.

Ayr Wellness (OTCMKTS:AYRWF) last issued its quarterly earnings data on Thursday, March 6th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.29) by ($0.12). Ayr Wellness had a negative net margin of 48.17% and a negative return on equity of 25.30%. The business had revenue of $113.96 million for the quarter, compared to analysts’ expectations of $114.10 million.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.